Abstract : [Background] Non -invasive detection of vascular dysfunction in the early stage is clinically important in patients with sleep apnea syndrome (SAS). Flow -mediated dilatation (FMD) is a novel clinical marker of endothelial function. However, it is not clear whether this is useful in the SAS patient.
INTRODUCTION
Sleep apnea syndrome (SAS) has a critical association with cardiovascular mortality and morbidity. It has been recently recognized that SAS plays a role in the pathogenesis of systemic hypertension, ischemic heart disease, heart failure, and arrhythmia 1) . Since an arteriosclerotic initial change to cause cardiovascular events is vascular endothelial dysfunction, the evaluation of endothelial function is clinically important. The assessment of flow -mediated dilatation (FMD) of the brachial artery has been recently used as a non -invasive method for evaluating endothelial function 2) . Therefore, the aim of this study was to examine whether endothelial function assessed by FMD is impaired in patients with SAS. We compared the FMD data between patients with mild SAS and those with moderate -severe SAS.
METHODS

Subjects and study protocol
In the present study, 129 patients with SAS were enrolled. SAS was diagnosed by polygraphic data. Apnea was defined as an absence of airflow for >10 s. Hypopnea was defined as a >30% reduc-tion in monitored airflow accompanied by a decrease in SaO 2 3−6) . We compared clinical characteristics, laboratory data, echocardiographic parameters, and FMD between the two groups. The study protocol was approved by the Ethics Committee of the Fukushima Medical University, and written informed consent was ob tained from all subjects.
Polygraphy
All subjects underwent overnight polygraphy with the use of standard techniques 7, 8) . Over night polygraphy was performed using a type 3 polygraph system (LS -300, Fukuda Denshi, Tokyo, Japan) that consisted of the monitoring of electrocardiogram, thoracoabdominal motion, nasal airflow by an airflow pressure transducer, and arterial oxyhemoglobin saturation (SpO 2 ) by pulse oximetry. Obstructive apnea was defined as the absence of airflow for ≧10 s associated with ribcage and abdominal motion. Central apnea was defined as the absence of airflow for >10 s associated without ribcage and abdominal motion. The major polygraphic parameters investigated were AHI, central apnea index (CAI), obstructive apnea index (OAI), lowest pulse oxygen saturation (Lowest SpO 2 ), and mean pulse oxygen saturation (Mean SpO 2 ) 7, 8) .
Echocardiography
Echocadiography was performed using the standard techniques. Two dimensional echocardiographic images were acquired from the parasternal long and short axis, apical long axis, and apical four chamber views by an experienced echocardiographer. The major echocardiographic parameters investigated were interventricular septal thickness (IVS), posterior wall thickness (PW), left ventricular mass index (LVMI), left atrial volume index (LAVI), left ventricular ejection fraction (LVEF), LV inflow E wave deceleration time (DcT), the ratio of LV inflow E wave to A wave peak velocity (E/A), and the ratio of transmitral early left ventricular filling velocity to early diastolic Doppler tissue imaging of the mitral annulus (E/e'). All recordings were performed on ultrasound systems (Acuson Sequoia, Siemens, Erlangen, Germany).
Flow -mediated dilatation (FMD) measurements
Endothelial function was evaluated by means of FMD within one week before or after polygraphy as previously reported 2) . After fasting for at least 5 hr, patients were required to lie at rest for at least 15 min, and FMD was assessed in the right arm in a supine position in a quiet temperature -controlled room by using high -resolution ultrasound (UNEXEF18G, UNEX Corporation, Nagoya, Japan). The brachial artery was scanned laterally and its diameter at end -diastole (from the inner border line of adventitia to adventitia) was measured. The cut off was obtained 5 cm proximal to the antecubital fossa, fitted at 8 cm distal to the brachial artery, near the wrist. The transmit focus zone was set at the depth of the anterior wall. Anatomical landmarks and snapshot images were used to assess FMD in the exact same vessel selection on each study day and at each time point. A view of a 5 cm transversal section of the brachial artery was recorded for periods of 30 s at the baseline and during the peak (up to 2 min after cuff release) reactive hyperemia (after deflation of the blood pressure cuff previously inflated to 50 mmHg above the patients' systolic blood pressure around the forearm for 5 min). The vessel diameter was automatically measured by built -in software. FMD was calculated as the percentage of change in diameter from the baseline value before cuff release to the peak value after cuff release : %FMD=[(vessel diameter reactive hyperemia−vessel diameter at rest)×100]/ vessel diameter at rest.
Statistical analysis
Data are presented as mean±SD. We used the chi -square test for categorical variables and the independent t -test for continuous variables. If the data were not distributed normally, the Mann -Whitney U test was used. A p value of <0.05 was considered significant for all comparisons. All analyses were performed using a statistical software package (StatView version 5.0, SAS Institute Inc., Abacus Concepts, Berkeley, CA, USA).
RESULTS
Clinical characteristics of study subjects
The clinical characteristics of Group A and Group B are shown in Table 1 . C -reactive protein was significantly higher in Group A than in Group B. However, there were no other differences in the laboratory data between the two groups.
Polygraphic data are shown in Table 2 . AHI, CAI and OAI were significantly higher in Group A than in Group B. The mean SpO 2 was significantly lower in Group A than in Group B.
Echocardiographic data are shown in Table 3 . There were no significant differences in all parameters between the two groups.
Results of FMD are shown in Figure 1 . The percentage of FMD was significantly lower in Group A than in Group B (3.5±1.6 vs. 7.8±3.1, P<0.01).
DISCUSSION
The influence of sleep apnea syndrome on cardiac function
Since obstruction of upper respiratory airway causes negative intra -thoracic pressure and hypoxia results in sympathetic nervous overactivity, SAS may contribute to cardiac systolic and diastolic dysfunction 4, 9, 10) . However in the present study, significant differences in cardiac function were not observed between mild and moderate -severe SAS in our study population. In a previous study by Romero -Corral et al 4) , severe SAS was associated with diastolic dysfunction (LAVI), but not systolic dysfunction (LVEF). Their study population included more severe SAS and OSA dominant compared to our study. In our study population, BMI and OAI were much lower than those in their study. These differences might relate to no significant changes in cardiac systolic and diastolic function even in moder- 
The influence of sleep apnea syndrome on endothelial function
Endothelial dysfunction is one of important cardiovascular risk factors and precede or accelerate the development of atherosclerosis 11−14) . It has been shown to have a clear predictive value for future cardiovascular event. A number of circulating markers of endothelial function including nitric oxide, soluble cell adhesion molecules, fibrinogen and plasminogen activator inhibitor have been reported to be altered in SAS 15) . 
